annual EBIT:
$18.69B+$3.42B(+22.36%)Summary
- As of today (April 12, 2025), NVO annual earnings before interest & taxes is $18.69 billion, with the most recent change of +$3.42 billion (+22.36%) on December 31, 2024.
- During the last 3 years, NVO annual EBIT has risen by +$9.25 billion (+97.86%).
- NVO annual EBIT is now at all-time high.
Performance
NVO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$4.99B-$195.17M(-3.76%)Summary
- As of today (April 12, 2025), NVO quarterly earnings before interest & taxes is $4.99 billion, with the most recent change of -$195.17 million (-3.76%) on December 31, 2024.
- Over the past year, NVO quarterly EBIT has stayed the same.
- NVO quarterly EBIT is now -3.76% below its all-time high of $5.19 billion, reached on September 30, 2024.
Performance
NVO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$19.01B+$1.31B(+7.40%)Summary
- As of today (April 12, 2025), NVO TTM earnings before interest & taxes is $19.01 billion, with the most recent change of +$1.31 billion (+7.40%) on December 31, 2024.
- Over the past year, NVO TTM EBIT has stayed the same.
- NVO TTM EBIT is now at all-time high.
Performance
NVO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.4% | 0.0% | 0.0% |
| 3 y3 years | +97.9% | +176.8% | +101.1% |
| 5 y5 years | +155.6% | +314.9% | +151.3% |
NVO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.9% | -3.8% | +338.7% | at high | +96.8% |
| 5 y | 5-year | at high | +155.6% | -3.8% | +338.7% | at high | +151.3% |
| alltime | all time | at high | >+9999.0% | -3.8% | +372.1% | at high | +2656.4% |
Novo Nordisk A/S EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.69B(+22.4%) | $4.99B(-3.8%) | $19.01B(+7.4%) |
| Sep 2024 | - | $5.19B(+33.6%) | $17.70B(+4.6%) |
| Jun 2024 | - | $3.88B(-21.6%) | $16.93B(+1.8%) |
| Mar 2024 | - | $4.95B(+34.4%) | $16.63B(+7.9%) |
| Dec 2023 | $15.28B(+55.2%) | $3.68B(-16.6%) | $15.41B(+19.8%) |
| Sep 2023 | - | $4.41B(+23.1%) | $12.87B(+12.9%) |
| Jun 2023 | - | $3.59B(-3.8%) | $11.40B(+6.7%) |
| Mar 2023 | - | $3.73B(+227.7%) | $10.68B(+8.2%) |
| Dec 2022 | $9.84B(+4.2%) | $1.14B(-61.4%) | $9.87B(-6.3%) |
| Sep 2022 | - | $2.95B(+2.6%) | $10.54B(+4.0%) |
| Jun 2022 | - | $2.87B(-1.7%) | $10.14B(+4.9%) |
| Mar 2022 | - | $2.92B(+61.9%) | $9.66B(+2.2%) |
| Dec 2021 | $9.45B(+15.2%) | $1.80B(-29.1%) | $9.45B(+1.7%) |
| Sep 2021 | - | $2.54B(+6.2%) | $9.30B(+5.7%) |
| Jun 2021 | - | $2.40B(-11.7%) | $8.79B(+4.0%) |
| Mar 2021 | - | $2.71B(+64.5%) | $8.46B(+3.7%) |
| Dec 2020 | $8.20B(+12.1%) | $1.65B(-19.1%) | $8.15B(+5.8%) |
| Sep 2020 | - | $2.04B(-1.0%) | $7.71B(+1.5%) |
| Jun 2020 | - | $2.06B(-14.6%) | $7.60B(+0.4%) |
| Mar 2020 | - | $2.41B(+100.2%) | $7.57B(+3.3%) |
| Dec 2019 | $7.31B(-3.2%) | $1.20B(-37.5%) | $7.33B(-2.5%) |
| Sep 2019 | - | $1.93B(-4.9%) | $7.51B(+1.1%) |
| Jun 2019 | - | $2.03B(-6.6%) | $7.42B(-1.3%) |
| Mar 2019 | - | $2.17B(+56.3%) | $7.52B(-1.1%) |
| Dec 2018 | $7.56B(+1.8%) | $1.39B(-24.7%) | $7.60B(-0.0%) |
| Sep 2018 | - | $1.84B(-13.2%) | $7.60B(-0.8%) |
| Jun 2018 | - | $2.12B(-5.7%) | $7.67B(+1.1%) |
| Mar 2018 | - | $2.25B(+62.1%) | $7.59B(+3.9%) |
| Dec 2017 | $7.42B(+4.3%) | $1.39B(-27.0%) | $7.30B(-1.8%) |
| Sep 2017 | - | $1.90B(-6.8%) | $7.44B(+0.6%) |
| Jun 2017 | - | $2.04B(+3.7%) | $7.40B(+2.0%) |
| Mar 2017 | - | $1.97B(+29.1%) | $7.26B(+2.1%) |
| Dec 2016 | $7.11B(+9.8%) | $1.53B(-18.1%) | $7.11B(+12.1%) |
| Sep 2016 | - | $1.86B(-1.8%) | $6.34B(+1.2%) |
| Jun 2016 | - | $1.90B(+4.1%) | $6.26B(+0.8%) |
| Mar 2016 | - | $1.82B(+140.8%) | $6.21B(-4.9%) |
| Dec 2015 | $6.48B(+6.4%) | $757.28M(-57.6%) | $6.53B(-7.1%) |
| Sep 2015 | - | $1.79B(-3.4%) | $7.03B(+3.0%) |
| Jun 2015 | - | $1.85B(-13.7%) | $6.83B(+2.6%) |
| Mar 2015 | - | $2.14B(+70.4%) | $6.66B(+9.2%) |
| Dec 2014 | $6.09B(+4.9%) | $1.26B(-20.5%) | $6.10B(-1.4%) |
| Sep 2014 | - | $1.58B(-5.7%) | $6.18B(+1.4%) |
| Jun 2014 | - | $1.68B(+6.0%) | $6.10B(+1.8%) |
| Mar 2014 | - | $1.58B(+17.8%) | $5.99B(+3.2%) |
| Dec 2013 | $5.80B(+20.6%) | $1.34B(-10.2%) | $5.80B(+5.9%) |
| Sep 2013 | - | $1.49B(-4.7%) | $5.47B(+3.3%) |
| Jun 2013 | - | $1.57B(+12.4%) | $5.30B(+4.3%) |
| Mar 2013 | - | $1.39B(+36.8%) | $5.08B(+5.4%) |
| Dec 2012 | $4.81B(+16.1%) | $1.02B(-22.8%) | $4.82B(+0.9%) |
| Sep 2012 | - | $1.32B(-2.0%) | $4.78B(+5.0%) |
| Jun 2012 | - | $1.35B(+18.7%) | $4.55B(+6.5%) |
| Mar 2012 | - | $1.13B(+16.0%) | $4.27B(+3.0%) |
| Dec 2011 | $4.15B(+24.0%) | $977.58M(-10.6%) | $4.15B(+6.6%) |
| Sep 2011 | - | $1.09B(+2.4%) | $3.89B(+5.5%) |
| Jun 2011 | - | $1.07B(+5.8%) | $3.69B(+5.2%) |
| Mar 2011 | - | $1.01B(+40.1%) | $3.51B(+5.1%) |
| Dec 2010 | $3.34B(+17.2%) | $720.73M(-19.0%) | $3.33B(+2.2%) |
| Sep 2010 | - | $889.81M(+0.5%) | $3.26B(+5.0%) |
| Jun 2010 | - | $885.45M(+5.5%) | $3.11B(+3.6%) |
| Mar 2010 | - | $838.98M(+29.1%) | $3.00B(+5.4%) |
| Dec 2009 | $2.85B(+16.8%) | $649.87M(-11.3%) | $2.85B(+9.1%) |
| Sep 2009 | - | $733.02M(-5.6%) | $2.61B(+0.5%) |
| Jun 2009 | - | $776.79M(+13.2%) | $2.59B(+7.5%) |
| Mar 2009 | - | $686.42M(+66.8%) | $2.41B(+1.5%) |
| Dec 2008 | $2.44B(+48.4%) | $411.63M(-42.7%) | $2.38B(+8.6%) |
| Sep 2008 | - | $718.81M(+20.5%) | $2.19B(+11.4%) |
| Jun 2008 | - | $596.69M(-8.3%) | $1.97B(+4.7%) |
| Mar 2008 | - | $650.48M(+190.8%) | $1.88B(+14.8%) |
| Dec 2007 | $1.65B(+7.3%) | $223.68M(-54.8%) | $1.64B(-7.9%) |
| Sep 2007 | - | $494.88M(-2.7%) | $1.78B(+4.0%) |
| Jun 2007 | - | $508.61M(+24.6%) | $1.71B(+3.9%) |
| Mar 2007 | - | $408.19M(+12.2%) | $1.64B(+6.7%) |
| Dec 2006 | $1.54B(+13.9%) | $363.90M(-14.8%) | $1.54B(+4.0%) |
| Sep 2006 | - | $426.95M(-3.8%) | $1.48B(+3.5%) |
| Jun 2006 | - | $443.88M(+45.7%) | $1.43B(+3.4%) |
| Mar 2006 | - | $304.64M(-0.2%) | $1.38B(+2.8%) |
| Dec 2005 | $1.35B(+14.7%) | $305.28M(-19.1%) | $1.35B(-2.2%) |
| Sep 2005 | - | $377.50M(-4.8%) | $1.38B(+7.1%) |
| Jun 2005 | - | $396.48M(+48.8%) | $1.29B(+7.6%) |
| Mar 2005 | - | $266.44M(-20.6%) | $1.19B(+1.1%) |
| Dec 2004 | $1.18B | $335.65M(+17.2%) | $1.18B(-258.8%) |
| Sep 2004 | - | $286.45M(-6.4%) | -$743.79M(+327.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $305.95M(+20.8%) | -$174.15M(-148.5%) |
| Mar 2004 | - | $253.37M(-115.9%) | $358.96M(-57.5%) |
| Dec 2003 | $973.92M(+28.1%) | -$1.59B(-285.7%) | $844.54M(+12.6%) |
| Sep 2003 | - | $856.09M(+2.0%) | $750.05M(+0.3%) |
| Jun 2003 | - | $839.06M(+13.5%) | $747.75M(+33.1%) |
| Mar 2003 | - | $738.95M(-143.9%) | $561.66M(+5.4%) |
| Dec 2002 | $760.15M(+13.0%) | -$1.68B(-297.2%) | $532.93M(-35.0%) |
| Sep 2002 | - | $853.80M(+30.8%) | $820.23M(+7.5%) |
| Jun 2002 | - | $652.97M(-8.1%) | $763.23M(-2.5%) |
| Mar 2002 | - | $710.22M(-150.8%) | $782.93M(+6.6%) |
| Dec 2001 | $672.69M(+27.9%) | -$1.40B(-275.3%) | $734.28M(+64.1%) |
| Sep 2001 | - | $796.80M(+18.5%) | $447.56M(-70.4%) |
| Jun 2001 | - | $672.68M(+1.7%) | $1.51B(-8.4%) |
| Mar 2001 | - | $661.56M(-139.3%) | $1.65B(-4.4%) |
| Dec 2000 | $525.93M(+25.6%) | -$1.68B(-190.4%) | $1.73B(+3.2%) |
| Sep 2000 | - | $1.86B(+129.8%) | $1.67B(+164.8%) |
| Jun 2000 | - | $810.58M(+9.9%) | $631.91M(+18.0%) |
| Mar 2000 | - | $737.25M(-142.4%) | $535.67M(+7.6%) |
| Dec 1999 | $418.81M(+95.5%) | -$1.74B(-311.5%) | $497.68M(+24.2%) |
| Sep 1999 | - | $821.66M(+15.0%) | $400.56M(+21.5%) |
| Jun 1999 | - | $714.35M(+2.2%) | $329.62M(+16.3%) |
| Mar 1999 | - | $699.25M(-138.1%) | $283.42M(+49.8%) |
| Dec 1998 | $214.19M(-39.5%) | -$1.83B(-344.4%) | $189.17M(-64.5%) |
| Sep 1998 | - | $750.72M(+12.4%) | $533.53M(+30.1%) |
| Jun 1998 | - | $668.15M(+10.4%) | $410.22M(+9.7%) |
| Mar 1998 | - | $605.00M(-140.6%) | $373.83M(+8.7%) |
| Dec 1997 | $354.00M(+3.6%) | -$1.49B(-337.5%) | $343.90M(-1.1%) |
| Sep 1997 | - | $627.41M(-0.7%) | $347.59M(-2.2%) |
| Jun 1997 | - | $631.76M(+9.9%) | $355.50M(+10.7%) |
| Mar 1997 | - | $575.07M(-138.7%) | $321.20M(-8.5%) |
| Dec 1996 | $341.54M(+2.1%) | -$1.49B(-334.0%) | $351.00M(+13.0%) |
| Sep 1996 | - | $635.32M(+6.3%) | $310.67M(+22.2%) |
| Jun 1996 | - | $597.46M(-1.2%) | $254.25M(-17.8%) |
| Mar 1996 | - | $604.87M(-139.6%) | $309.26M(+10.6%) |
| Dec 1995 | $334.50M(+15.3%) | -$1.53B(-363.8%) | $279.55M(-39.6%) |
| Sep 1995 | - | $578.90M(-11.3%) | $462.93M(+7.2%) |
| Jun 1995 | - | $652.47M(+13.4%) | $431.98M(+41.5%) |
| Mar 1995 | - | $575.16M(-142.8%) | $305.32M(+57.9%) |
| Dec 1994 | $290.00M(-3.4%) | -$1.34B(-345.2%) | $193.31M(-61.2%) |
| Sep 1994 | - | $547.95M(+4.2%) | $498.12M(+20.1%) |
| Jun 1994 | - | $525.81M(+13.5%) | $414.84M(+11.2%) |
| Mar 1994 | - | $463.15M(-144.6%) | $373.05M(+13.9%) |
| Dec 1993 | $300.23M(+56.1%) | -$1.04B(-323.6%) | $327.44M(+42.2%) |
| Sep 1993 | - | $464.66M(-4.0%) | $230.21M(+4.7%) |
| Jun 1993 | - | $484.02M(+15.9%) | $219.90M(+17.9%) |
| Mar 1993 | - | $417.53M(-136.8%) | $186.47M(-3.2%) |
| Dec 1992 | $192.36M(-12.6%) | -$1.14B(-350.0%) | $192.69M(-58.0%) |
| Sep 1992 | - | $454.35M(+0.8%) | $458.91M(+27.5%) |
| Jun 1992 | - | $450.60M(+6.3%) | $359.94M(+45.3%) |
| Mar 1992 | - | $423.75M(-148.7%) | $247.65M(+17.7%) |
| Dec 1991 | $220.07M(+29.1%) | -$869.78M(-344.7%) | $210.43M(-4.3%) |
| Sep 1991 | - | $355.38M(+5.1%) | $219.95M(+10.7%) |
| Jun 1991 | - | $338.30M(-12.5%) | $198.62M(+11.5%) |
| Mar 1991 | - | $386.54M(-144.9%) | $178.09M(+99.9%) |
| Dec 1990 | $170.48M(+18.5%) | -$860.27M(-357.5%) | $89.08M(-72.2%) |
| Sep 1990 | - | $334.06M(+5.1%) | $320.60M(+45.5%) |
| Jun 1990 | - | $317.76M(+6.8%) | $220.29M(+61.6%) |
| Mar 1990 | - | $297.53M(-147.3%) | $136.35M(+19.6%) |
| Dec 1989 | $143.85M(+3.2%) | -$628.74M(-369.0%) | $113.96M(-61.5%) |
| Sep 1989 | - | $233.75M(-0.0%) | $295.66M(+19.7%) |
| Jun 1989 | - | $233.82M(-15.0%) | $247.03M(+9.3%) |
| Mar 1989 | - | $275.14M(-161.5%) | $226.03M(+66.2%) |
| Dec 1988 | $139.39M(+47.1%) | -$447.04M(-341.5%) | $136.02M(+8.2%) |
| Sep 1988 | - | $185.12M(-13.0%) | $125.67M(+3.7%) |
| Jun 1988 | - | $212.81M(+15.0%) | $121.19M(+51.2%) |
| Mar 1988 | - | $185.13M(-140.5%) | $80.13M(+12.1%) |
| Dec 1987 | $94.76M(+14.3%) | -$457.39M(-353.2%) | $71.49M(-64.6%) |
| Sep 1987 | - | $180.64M(+5.2%) | $202.13M(+34.0%) |
| Jun 1987 | - | $171.75M(-2.7%) | $150.89M(+33.6%) |
| Mar 1987 | - | $176.49M(-154.0%) | $112.91M(+105.3%) |
| Dec 1986 | $82.91M(+18.9%) | -$326.75M(-352.5%) | $55.00M(-56.7%) |
| Sep 1986 | - | $129.40M(-3.3%) | $126.97M(+35.8%) |
| Jun 1986 | - | $133.77M(+12.8%) | $93.51M(+70.1%) |
| Mar 1986 | - | $118.58M(-146.5%) | $54.98M(+90.2%) |
| Dec 1985 | $69.75M(+26.2%) | -$254.79M(-365.6%) | $28.90M(-65.6%) |
| Sep 1985 | - | $95.94M(+0.7%) | $83.91M(+5.5%) |
| Jun 1985 | - | $95.24M(+3.0%) | $79.51M(+5.4%) |
| Mar 1985 | - | $92.51M(-146.3%) | $75.44M(+0.5%) |
| Dec 1984 | $55.29M | -$199.77M(-318.2%) | $75.07M(-72.7%) |
| Sep 1984 | - | $91.54M(+0.4%) | $274.84M(+49.9%) |
| Jun 1984 | - | $91.16M(-1.1%) | $183.30M(+98.9%) |
| Mar 1984 | - | $92.14M | $92.14M |
FAQ
- What is Novo Nordisk A/S annual earnings before interest & taxes?
- What is the all time high annual EBIT for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual EBIT year-on-year change?
- What is Novo Nordisk A/S quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly EBIT year-on-year change?
- What is Novo Nordisk A/S TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM EBIT year-on-year change?
What is Novo Nordisk A/S annual earnings before interest & taxes?
The current annual EBIT of NVO is $18.69B
What is the all time high annual EBIT for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual earnings before interest & taxes is $18.69B
What is Novo Nordisk A/S annual EBIT year-on-year change?
Over the past year, NVO annual earnings before interest & taxes has changed by +$3.42B (+22.36%)
What is Novo Nordisk A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of NVO is $4.99B
What is the all time high quarterly EBIT for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly earnings before interest & taxes is $5.19B
What is Novo Nordisk A/S quarterly EBIT year-on-year change?
Over the past year, NVO quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Novo Nordisk A/S TTM earnings before interest & taxes?
The current TTM EBIT of NVO is $19.01B
What is the all time high TTM EBIT for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM earnings before interest & taxes is $19.01B
What is Novo Nordisk A/S TTM EBIT year-on-year change?
Over the past year, NVO TTM earnings before interest & taxes has changed by $0.00 (0.00%)